Jeremy Hague

Jeremy Hague

Company: Enzymlogic

Job title: Chief Business Development Officer


Kinetic Profiling of Reversible & Irreversible Kinase Inhibitors : At Scale & Speed 10:10 am

Why kinetic profiling matters in drug discovery Enzymlogic’s KINETICfinder® and COVALfinder® platforms: optimized for reversible and irreversible inhibitor kinetic profiling in early discovery Case studies that illustrate: How kinetic profiling reinforces drug discovery decision making Kinetic Selectivity is a superior predictor of efficacy compared to Affinity Selectivity How Enzymlogic supports your kinetic investigationRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.